Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.70
Bid: 0.00
Ask: 60.00
Change: 0.00 (0.00%)
Spread: 20.60 (52.284%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 39.70
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING: Zambeef sees profit above market views; Luceco trades in line

Tue, 07th Nov 2023 17:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Luceco PLC - London-based lighting manufacturer and distributor - Says that in the three months ended September 30, it traded in line with expectations. Revenue in the third quarter was 8.3% ahead of the prior year. Looking ahead, Luceco left its full-year guidance unchanged. Chief Executive Officer John Hornby says: "Whilst demand from energy saving professional projects continues its positive path; we are seeing some impact of reduced demand in certain of our end markets as the UK consumer continues to experience economic headwinds. Luceco's strong cash generation in the quarter was particularly encouraging, and with our low levels of net debt, the group is well placed to invest in growth and enhance earnings in line with strategic priorities."

----------

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Further expands partnership with M8 Pharmaceuticals Inc. Says M8 has taken up its rights to extend its licensing agreement from Brazil and Mexico to market MED3000 in a further fourteen countries throughout the Central and South American region. Futura has received an undisclosed upfront milestone payment from M8 as part of the extended agreement. The extension builds on the agreement signed in August 2021. Apart from the geographic expansion, the commercial terms and initial duration of the agreement remain unchanged. CEO James Barder says: "This is another major step forward in the execution of Futura's strategy. M8 is an excellent partner with dedicated brand-building and marketing experience, as well as scale and strong pharmaceutical connections in South and Central America and we look forward to working closely with them across the Latin American region."

----------

Vianet Group PLC - Stockton-on-Tees, England-based provider of retail sales and volume monitoring systems - Intends to conduct on-market purchases under a share buyback programme. The programme, which will be funded from its existing cash resources, is intended to reduce the share capital of the company. The buyback will begin immediately and will close at the conclusion of the 2024 annual general meeting, or September 5.

----------

Scotgold Resources Ltd - Stirlingshire, Scotland-based gold and silver exploration company's- Says it is considering the appointment of administrators "over the coming days." In October, Scotgold said it was in "advanced" financing discussions with a strategic investor, but now says the discussions "have not resulted in an investment at this time." Its share were suspended in September, pending clarification of its financial position.

----------

Zambeef Products PLC - Lusaka-based cold chain foods and retail business with operations in Zambia, Nigeria and Ghana - Says forward guidance on financial trading performance for the year ended September 30 is expected to be above market expectations, despite a challenging operating environment. Says revenue, gross profit and adjusted earnings before interest, tax, depreciation and amortisation are expected to be between 5-15% higher than market expectations. Reported pretax profit is expected to be about 30% higher than current market expectations. "The group continued to see increasing demand for its products, supported by a price moderation approach, resulting in volume growth across most product categories. Lower than expected selling prices and higher input costs (which couldn't fully be passed on to the consumer), including fuel and electricity, put pressure on gross margins which moderated in the second half," it says.

----------

F&C Investment Trust PLC - aims for long-term growth and income by investing in listed equities globally - Says that a third dividend for 2023 will be paid. Ups quarterly dividend to 3.40p from 3.20p a year earlier. Looking ahead, F&C plans to deliver another rise in our total dividend for this year, which will be the 53rd consecutive annual rise.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
18 Jun 2018 13:25

European Wealth Appoints Jonathan Freeman As Non-Executive Director

LONDON (Alliance News) - European Wealth Group Ltd said Monday it appointed Jonathan Freeman as non-executive director.Freeman currently holds the roles of non-executive chairman of LED of

Read more
13 Jun 2018 12:36

Futura Says Licensing Of Erectile Dysfunction Gel Remains Top Priority

LONDON (Alliance News) - Futura Medical PLC Chairman John Clarke said Wednesday the company continues to make "good progress" both in product development and commercialisation.In

Read more
26 Apr 2018 13:53

Futura Medical Begins Groundwork For MED 2002 Phase III Trial

LONDON (Alliance News) - Healthcare firm Futura Medical PLC said Thursday it has started preparing for a phase III trial for its proposed erectile dysfunction gel MED 2002.This trial what a

Read more
14 Mar 2018 16:08

Futura Medical Annual Loss Widens On Higher Research Costs

LONDON (Alliance News) - Futura Medical PLC said Wednesday that planned increase in research and development expenditure for the development of erectile dysfunction gel has in

Read more
10 Jan 2017 11:05

Futura Medical signs license agreement with Thornton & Ross

(ShareCast News) - Futura Medical, an AIM listed innovative healthcare company focused on transdermal technology, has signed a licensing agreement with Thornton & Ross for the commercialisation of TPR100, the company's novel diclofenac gel for pain relief. Thornton & Ross (T&R) is one of the largest

Read more
16 Nov 2016 09:28

Futura To Develop Two Dose Strengths Of Erectile Dysfunction Gel

Read more
27 Oct 2016 14:24

Futura Medical partner approved for erectogenic condom manufacture

(ShareCast News) - Advanced transdermal technology-focused healthcare company Futura Medical announced on Thursday that, as anticipated, its regulatory submission to allow TTK Protective Devices to manufacture its erectogenic condom, CSD500, has been approved by the relevant EU Notified Body with an

Read more
27 Oct 2016 08:11

Futura Medical To Raise Up To GBP12 Million To Speed Up Products (ALLISS)

Read more
7 Sep 2016 10:35

Futura Medical perks up on 'breakthrough' erectile dysfunction study

(ShareCast News) - Shares in AIM-listed Futura Medical perked up to a two-year high as the company revealed that trials of its erectile dysfunction (ED) treatment had found it to be effective, safe and with the potential to be the fastest-acting product on the market. A clinical study of Futura's ME

Read more
7 Sep 2016 07:25

LONDON BRIEFING: Change At Top For Well-Performing Hargreaves Lansdown

Read more
7 Sep 2016 07:11

Futura Medical Gets Positive Results On Erectile Dysfunction Gel

Read more
21 Jun 2016 07:11

Futura Medical Sees "Clear Potential For Value Generation This Year"

Read more
20 Jun 2016 07:26

Futura Medical Signs Southeast Europe Distribution Deal For Condom

Read more
14 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more
13 Jun 2016 10:13

Futura Signs Manufacturing And Indian Distribution Deal For New Condom

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.